GlassScriptPhysician profile
Marja J Sprock
NPI 1336216704
$20,911.69
in general payments reported to CMS, 2019-2025
59 companies · $3,396 in 2025
The $3,396 reported for 2025 was more than what 89% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,769 · 2020: $1,311 · 2021: $4,647 · 2022: $3,316 · 2023: $2,834 · 2024: $2,638 · 2025: $3,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,726 · Travel and Lodging: $1,041 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,726.37 |
| Travel and Lodging | $1,041.22 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,505.46 | 2020-2024 | Axonics |
| Medtronic, INC. | $1,828.47 | 2021-2025 | Interstim |
| Medtronic USA, INC. | $1,511.06 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $1,487.19 | 2020-2025 | Farxiga, Imfinzi, Lynparza |
| Astellas Pharma US INC | $1,259.91 | 2019-2025 | Veozah, Xtandi, Myrbetriq |
| Valencia Technologies Corporation | $878.11 | 2022-2025 | Ecoin Device Kit |
| Janssen Biotech, INC. | $524.32 | 2021-2025 | Rybrevant, Carvykti, Erleada |
| Glaxosmithkline, LLC. | $497.38 | 2021-2024 | Ojjaara, Zejula |
| Amgen INC. | $494.75 | 2021-2025 | Blincyto, Kyprolis, Lumakras |
| Daiichi Sankyo INC. | $393.36 | 2020-2024 | Enhertu |
| Incyte Corporation | $372.91 | 2020-2024 | Jakafi, Monjuvi, Pemazyre |
| E.R. Squibb & Sons, L.L.C. | $365.02 | 2021-2025 | Opdivo, Reblozyl |
| Boston Scientific Corporation | $361.40 | 2023-2025 | Axonics, Solyx Sis System |
| Seagen INC. | $350.52 | 2021-2023 | Tukysa |
| Janssen Pharmaceuticals, INC | $343.59 | 2019-2021 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marja Sprock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.